Core Scientific Pivots Pecos Site to 1.5GW AI Campus

NEW YORK, April 29 —

Core Scientific (CORZ) is doing what every former Bitcoin miner with a power contract is now trying to do: re-skin itself as an AI infrastructure landlord. The company filed an 8-K on April 27 tied to its Pecos, Texas campus, and news coverage frames the project as a 1.5-gigawatt expansion marketed for lease to AI tenants, with capacity referenced for early 2027. The pitch arrives nine days before Q1 earnings on May 6 — and against a steady tape of insider sales that has not paused for the rebrand.

What the Pecos pivot actually is

Strip the press release language out and the deal is simple: Core Scientific has a large parcel in West Texas with grid interconnect, and it would rather rent that interconnect to a hyperscaler than mine bitcoin on it. The April 27 disclosure was filed under Item 7.01, the Regulation FD bucket companies use for press releases and investor events that aren't quite material-contract news. Six days earlier, on April 21, the company filed a similar Reg FD 8-K. Two Reg FD filings in a week is the SEC equivalent of a company tapping the microphone.

The substance, per news coverage, is a 1.5-gigawatt gross-power figure for the Pecos site and a marketing posture aimed at AI data center tenants, with early 2027 referenced as the capacity timing. That is a long sales cycle for a building that does not yet exist at that scale, which means the announcement is a leasing pitch as much as a development update. The structure also matters: a triple-net lease to a hyperscaler is a fundamentally different business than self-mining bitcoin, with different cash-flow characteristics, different capex curves, and a different shareholder base.

The financing buildup nobody is talking about

The Pecos headline is loud, but the more telling filings landed earlier in March. On March 6 and again on March 23, Core Scientific filed 8-Ks covering Items 1.01, 2.03, and 8.01 — entry into a Material Definitive Agreement, creation of a Material Direct Financial Obligation, and Other Events. In plain English: the company signed two material contracts and took on two material financial obligations, three weeks apart. External commentary frames the strategy as rebuilding the equity narrative around AI infrastructure growth funded by debt, with debt-related risks called out alongside the pivot.

Sandwiched between those was a more uncomfortable disclosure. The March 2 8-K reported quarterly results under Item 2.02, but it also flagged Item 4.02 — Non-Reliance on Previously Issued Financial Statements. A 4.02 is the disclosure companies file when prior numbers have to be unwound. Investors heading into the May 6 print should already be discounting historical comparables.

The insiders are not waiting for the lease announcement

The Form 4 file for CORZ over the period is the kind of pattern that does not square neatly with a turnaround narrative. CEO Adam Sullivan's March 31 grant of 741,545 shares is the largest event by share count, and 315,307 of those shares were immediately dispositioned at $14.96 to cover the tax bill — a $4.72M outflow. Two weeks later, on April 15, another 87,355 of his shares were dispositioned at $19.08 for $1.67M, also for tax withholding.

Tax-withholding dispositions are mechanical — they happen because the IRS gets paid in cash, not stock — so they aren't, on their own, evidence of conviction either way. CFO James Nygaard's 92,725-share disposition at $16.42 on March 17, totaling $1.52M, falls in the same category.

What does not fall in that category is Todd M. Duchene's selling. Duchene executed five open-market sales in roughly three weeks: 10,000 shares at $15.25 on April 1, 10,000 at $16.49 on April 6, 9,600 at $18.61 plus 400 at $18.99 on April 13, and 10,000 at $19.80 on April 20. Those are voluntary lots, sized and timed by the seller, and they trace a price ladder that runs straight up into the Pecos announcement. The director-level offset is small and stale: Eric Stanton Weiss bought 7,000 shares at $14.53 on March 9 for roughly $102,000. That is the only insider open-market buy in the period. Net, Form 4 activity over the window came to roughly $0.10M of insider purchases against $0.70M of open-market sales.

Five non-officer directors — Jeffrey David Booth, Jordan Levy, Elizabeth Crain, Yadin Rozov, and Eric Stanton Weiss — also each received 18,575-share grants on February 4, the housekeeping refresh that tends to accompany a new board year. None of those are signal; the Duchene cadence is.

The fundamentals the market is pricing through

At $19.53 and a $6.16B market cap, CORZ trades on a forward narrative, not on its trailing financials. Trailing-twelve-month revenue is $0.32B and growth is running at -16.0% — the pre-pivot business is shrinking. Gross margin is 17.1%, which is what mining economics look like when compute is being repriced. Free cash flow is -$539M. The forward P/E sits at 46.5x; the analyst consensus target is $26.55.

Recent EPS prints have been choppy versus consensus: -$0.13 against a $0.02 estimate four quarters ago, $0.07 against $0.01 three quarters ago, and -$0.20 against $0.07 two quarters ago. That is the kind of variance that makes the May 6 webcast — scheduled for 3:30 p.m. CT — a checkpoint rather than a coronation. The company also filed its definitive proxy and additional proxy materials on March 31, normal annual-meeting plumbing but worth knowing for governance vote watchers.

The shareholder base is starting to move around the story too. Third-party reporting notes Moody Aldrich Partners LLC sold 257,642 shares, while separate coverage characterizes Howard Marks as holding a bullish position. Those are external claims, not filings, but they bracket the kind of debate now forming around the name: distressed-credit hands like the asset, generalist long-onlys aren't all sticking around for the rerate.

What to watch on and after May 6

The Q1 print is the next forced disclosure. Three things are worth tracking:

• Pecos lease language. A signed anchor tenant, even a small one, would convert the 1.5GW figure from marketing to backlog. Without one, the campus is still a brochure.
• The shape of the new debt. The March 6 and March 23 Material Definitive Agreements need to show up in the balance sheet and the MD&A. Coupon, tenor, covenants, and any equity-linked features will define how punitive the AI pivot's financing actually is.
• Insider cadence after the print. If Duchene's open-market lots continue at the same weekly rhythm into a post-earnings window, that is its own data series. Tax-withholding dispositions will keep happening regardless of price; voluntary sales will not.

The non-reliance flag from the March 2 filing also means restated comparables are likely embedded in the May 6 release. Expect the year-ago line to look different than memory suggests.

Run the free Core Scientific, Inc. deep-dive →

Basis Report does not hold positions in securities discussed. This is not investment advice.

Frequently Asked Questions

What is Core Scientific's Pecos AI data center plan?

Per the April 27 8-K and supporting coverage, Core Scientific is repositioning its Pecos, Texas campus to 1.5 gigawatts of gross power and marketing the site for lease to AI tenants, with early 2027 capacity referenced. Details and the financing context are in the analysis above.

When does Core Scientific report Q1 earnings?

Core Scientific has confirmed it will post Q1 results on May 6, with the webcast starting at 3:30 p.m. CT. The article above lays out the three things to watch on the call.

Are Core Scientific insiders selling stock?

Yes. CEO Adam Sullivan had $4.72M in shares dispositioned on March 31 and $1.67M more on April 15 for tax withholding, while insider Todd Duchene executed five open-market sales in April. The full cadence and the lone insider buy are detailed above.

What did Core Scientific's March 8-K filings disclose?

The March 6 and March 23 8-Ks each disclosed entry into a Material Definitive Agreement and creation of a Material Direct Financial Obligation, while the March 2 8-K flagged Non-Reliance on Previously Issued Financial Statements. The implications for the May 6 print are covered in the financing section above.

How much revenue does Core Scientific generate?

Trailing-twelve-month revenue is $0.32 billion, with revenue growth of -16.0%, gross margin of 17.1%, and free cash flow of -$539 million. The full fundamentals snapshot — including the 46.5x forward P/E and $26.55 analyst target — is broken down above.